Drug Profile
SR 0379
Alternative Names: SR-0379Latest Information Update: 24 Aug 2023
Price :
$50
*
At a glance
- Originator Osaka University School of Medicine
- Developer Shionogi
- Class Anti-infectives; Peptide antibiotics; Peptides
- Mechanism of Action Angiogenesis inducing agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Skin ulcer